At the capital markets day at the end of March, Kühne + Nagel revised its strategy named «Roadmap 26.» Previously, the focus ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Roche slightly surpassed revenue expectations in the first three months. The company reaffirms its full-year guidance.

Overall, the company from Vevey reported revenue of CHF 22.6 billion in the first three months of the new year, as announced ...

Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

After Accelleron, ABB is preparing its next billion dollar Spin-off. The new CEO is making his mark and delivers good results ...

Investors remained cautious after Donald Trump’s far-reaching tariff exemptions at the weekend – including Apple. Meanwhile, ...

Philip Morris shares have risen by more than 50% in the past twelve months – the transformation is going well. In an ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Following the recent near-financial crash, calls to exclude US government bonds from banks’ capital ratios are growing louder ...

The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is ...